104 related articles for article (PubMed ID: 2478017)
21. Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2.
Kleiner DE; Unsworth EJ; Krutzsch HC; Stetler-Stevenson WG
Biochemistry; 1992 Feb; 31(6):1665-72. PubMed ID: 1310615
[TBL] [Abstract][Full Text] [Related]
22. Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Expression of collagen type I, collagenase, stromelysin and tissue inhibitor of metalloproteinases.
Colige AC; Lambert CA; Nusgens BV; Lapière CM
Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):215-21. PubMed ID: 1637302
[TBL] [Abstract][Full Text] [Related]
23. Monocyte procollagenase and tissue inhibitor of metalloproteinases. Identification, characterization, and regulation of secretion.
Campbell EJ; Cury JD; Lazarus CJ; Welgus HG
J Biol Chem; 1987 Nov; 262(33):15862-8. PubMed ID: 2824471
[TBL] [Abstract][Full Text] [Related]
24. Generalized eruptive xanthoma with prominent deposition of naked chylomicrons: evidence for chylomicrons as the origin of urate-like crystals.
Bito T; Kawakami C; Shimajiri S; Tokura Y
J Cutan Pathol; 2010 Nov; 37(11):1161-3. PubMed ID: 20849458
[TBL] [Abstract][Full Text] [Related]
25. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase.
Murphy G; Reynolds JJ; Werb Z
J Biol Chem; 1985 Mar; 260(5):3079-83. PubMed ID: 2982848
[TBL] [Abstract][Full Text] [Related]
26. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis.
Riley GP; Harrall RL; Watson PG; Cawston TE; Hazleman BL
Eye (Lond); 1995; 9 ( Pt 6)():703-18. PubMed ID: 8849537
[TBL] [Abstract][Full Text] [Related]
27. Extracellular collagenase, proteoglycanase and products of their activity, released in organ culture by intact dermal inflammatory lesions produced by sulfur mustard.
Woessner JF; Dannenberg AM; Pula PJ; Selzer MG; Ruppert CL; Higuchi K; Kajiki A; Nakamura M; Dahms NM; Kerr JS
J Invest Dermatol; 1990 Dec; 95(6):717-26. PubMed ID: 2174450
[TBL] [Abstract][Full Text] [Related]
28. Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products.
Rifas L; Halstead LR; Peck WA; Avioli LV; Welgus HG
J Clin Invest; 1989 Aug; 84(2):686-94. PubMed ID: 2547836
[TBL] [Abstract][Full Text] [Related]
29. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4.
Lacraz S; Nicod L; Galve-de Rochemonteix B; Baumberger C; Dayer JM; Welgus HG
J Clin Invest; 1992 Aug; 90(2):382-8. PubMed ID: 1322938
[TBL] [Abstract][Full Text] [Related]
30. Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma.
Saarialho-Kere UK; Chang ES; Welgus HG; Parks WC
J Clin Invest; 1992 Nov; 90(5):1952-7. PubMed ID: 1430217
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast heterogeneity in collagenolytic response to cyclosporine.
Tipton DA; Stricklin GP; Dabbous MK
J Cell Biochem; 1991 Jun; 46(2):152-65. PubMed ID: 1655819
[TBL] [Abstract][Full Text] [Related]
32. Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells.
Gavrilovic J; Hembry RM; Reynolds JJ; Murphy G
J Cell Sci; 1987 Mar; 87 ( Pt 2)():357-62. PubMed ID: 2821028
[TBL] [Abstract][Full Text] [Related]
33. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts.
Clark SD; Kobayashi DK; Welgus HG
J Clin Invest; 1987 Nov; 80(5):1280-8. PubMed ID: 2824558
[TBL] [Abstract][Full Text] [Related]
35. Immunolocalization of collagenase and tissue inhibitor of metalloproteinases (TIMP) in hypertrophic scar tissue.
Hembry RM; Ehrlich HP
Br J Dermatol; 1986 Oct; 115(4):409-20. PubMed ID: 3022783
[TBL] [Abstract][Full Text] [Related]
36. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells.
Shingu M; Nagai Y; Isayama T; Naono T; Nobunaga M; Nagai Y
Clin Exp Immunol; 1993 Oct; 94(1):145-9. PubMed ID: 8403497
[TBL] [Abstract][Full Text] [Related]
37. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts.
Miltenburg AM; Lacraz S; Welgus HG; Dayer JM
J Immunol; 1995 Mar; 154(6):2655-67. PubMed ID: 7876539
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases in periodontal tissue remodelling.
Sodek J; Overall CM
Matrix Suppl; 1992; 1():352-62. PubMed ID: 1480060
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity.
Ponton A; Coulombe B; Skup D
Cancer Res; 1991 Apr; 51(8):2138-43. PubMed ID: 1849044
[TBL] [Abstract][Full Text] [Related]
40. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
